CRDF R&D to Revenue
Cardiff Oncology Inc · R&D to Revenue
CRDF R&D to Revenue
Latest reported5957.67%period ending
CRDF FY R&D/Revenue (0.00% → 5957.67%)
Latest values, visible window
High-resolution chart · PNG
CRDF r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5,957.6728% | |
| 5,395.6076% | |
| 6,732.9918% | |
| 7,022.5389% | |
| 4,840.1114% | |
| 3,069.6721% | |
| 4,562.8683% | |
| 2,159.7884% | |
| 1,560.9901% | |
| 3,938.8451% | |
| 3,384.6645% | |
| 2,380.3571% | |
| 1,522.7193% | |
| 426.6667% | |
| 353.3951% | |
| 1,389.3543% | |
| 0% | |
| 0% | |
| 0% |